TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Abbott Laboratories Investors File Lawsuit Against Directors Alleging Breaches Of Fiduciary Duties

  • If you purchased shares of Abbott Laboratories (NYSE: ABT), and / or if you have any information relating the investigation including those who are former employees or/and whistleblowers, you may have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

San Diego, Nov. 28, 2011 (Shareholders Foundation) -- An investor in NYSE ABT shares filed a lawsuit against directors of Abbott Laboratories (NYSE: ABT) over alleged breaches of fiduciary duty in connection with alleged off-label marketing of Depakote that cost Abbott Laboratories $1.3billion settlement with the US Government and 24 states. According to the complaint the plaintiff a...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: